Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RESCUE: Discontinuation of GLP-1

NCT: NCT07190794 · TERMINATED

NCT IDNCT07190794
StatusTERMINATED
Start Date2025-12-17
Completion2026-05-26
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

This study is designed to compare weight loss outcomes and safety of ESG versus lifestyle modification in patients with obesity who discontinued GLP-1 therapy due to intolerance or suboptimal weight loss.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑